Peptides

Tesamorelin

Rx · Prescription onlyInjected under the skin

Tesamorelin

Targets belly fat.

Your plan

$179/mo, $1,074 billed once for 6 months/mo

$1,074 billed once for 6 months · unused months refunded on a medical stop

No membership fee · this is the full price · free shipping · avg 4-week supply

Get started
  • Medication, clinician care and dose adjustments, all in one price.
  • ~28-day supply. Your clinician sets your exact dose, so yours may vary; your refill arrives as you finish the last one.

A licensed clinician on our care team reviews every request and prescribes only when it's clinically appropriate.

FDA status: Compounded medication, not FDA-approved.

What it's for

Who it's for

Adults whose main concern is fat around the waist and organs.

How it's different

The only growth hormone peptide with an FDA approval, for abdominal fat in people with HIV. Here it is used off-label at a lower dose.

How it works

Tesamorelin is a synthetic version of growth hormone-releasing hormone (GHRH). It signals the pituitary gland to release your own growth hormone in its natural pulses. Growth hormone output falls with age, and with it the body's ability to burn deep abdominal fat and hold lean mass. Tesamorelin is the GHRH analog most studied for reducing visceral fat.

How to use it and what arrives

1 vial · lasts 4 weeks

Your clinician sets your dose: 0.6 mg · same price at every dose

How
Injected under the skin
How often
5 days a week
When
At bedtime

Good to know

The fat it removes comes back after stopping. Think of it as part of a plan, not a one-time fix.

What the research shows

A GHRH analogue with a current FDA label for excess abdominal fat in adults with HIV-associated lipodystrophy. It has randomized trials in people, the largest in 412 adults with HIV, but only for that narrow use.

  1. HIV belly fat

    about 15% less visceral fat

    In 412 adults with HIV and excess abdominal fat, 2 mg injected daily for 26 weeks reduced visceral fat by about 15%. Most participants (86%) were men.

    Falutz et al., N Engl J Med 2007
  2. FDA label

    one approved use

    The US label (EGRIFTA WR and SV, revised March 2025) is for reducing excess abdominal fat in HIV-infected adults with lipodystrophy. It says long-term cardiovascular safety has not been established and that the drug is not indicated for weight loss.

    EGRIFTA WR and SV prescribing information, FDA
  3. Cognition

    small older-adult trial

    Baker et al. (Arch Neurol 2012) gave tesamorelin 1 mg at bedtime for 20 weeks to 152 adults aged 55 to 87, 66 of them with mild cognitive impairment. Cognition improved more than on placebo across the group, most clearly for executive function.

    Baker et al., Arch Neurol 2012

The HIV trials used the 2 mg daily dose of the 1 mg-per-vial formulation, which the label describes as EGRIFTA WR. The benefit is for fat in one area, not for general weight or health. Compounded or research-grade tesamorelin was not the product studied.

What this does not say

  • Approved use is limited to HIV-associated abdominal fat; it is not approved for weight loss or longevity.
  • The label warns of an increased risk of neoplasms (cancer) and says long-term cardiovascular safety has not been established.
  • IGF-1 rises during treatment, and the label says the effects of prolonged elevation are unknown.
  • The ipamorelin partner in the blend has only the evidence on its own page; the combination was not tested together.

Sources

  1. Tesamorelin reduced visceral abdominal fat and improved lipids over 26 weeks in a randomized, placebo-controlled trial. New England Journal of Medicine, 2007 (Falutz J et al.)
  2. Pooled analysis of two phase 3 trials: sustained reduction in visceral fat with tesamorelin, with a well-characterized safety profile. Journal of Clinical Endocrinology & Metabolism, 2010 (Falutz J et al.)
  3. Tesamorelin reduced liver fat in a randomized, double-blind trial. The Lancet HIV, 2019 (Stanley TL et al.)
  4. Growth hormone-releasing hormone improved cognitive function in healthy older adults and adults with mild cognitive impairment. Archives of Neurology, 2012 (Baker LD et al.)
Read the full research

Safety

FDA status: Compounded medication, not FDA-approved.

Side effects and precautions

  • Tesamorelin is generally well tolerated.
  • Common, mild effects include redness, itching or swelling at the injection site, joint or muscle aches, tingling in the hands, mild fluid retention and headache, usually in the first weeks.
  • It can raise blood sugar, so your clinician may check glucose, especially if you have diabetes or prediabetes.
  • Not for people with an active cancer, a pituitary disorder, during pregnancy or breastfeeding.

Get care right away

  • Stop and seek care for hives, swelling of the face or lips or trouble breathing.

Tell your clinician about every medication you take, including steroids and thyroid hormone.

Questions

How is Tesamorelin different from Sermorelin?

Both are GHRH analogs that make your pituitary release your own growth hormone. Tesamorelin is longer-acting and is the one studied specifically for reducing visceral abdominal fat; sermorelin is more often used for sleep, recovery and general growth hormone support.

How is it taken?

A small subcutaneous injection, usually once a day at night, when your body naturally releases growth hormone. Your clinician sets the dose and schedule; your kit includes everything.

What are the side effects?

Most people tolerate it well. The most common effects are mild: redness or itching where you inject, joint aches, tingling in the hands, mild fluid retention or headache. It can raise blood sugar, which your clinician monitors. Stop and seek care for hives, swelling or trouble breathing.

Is Tesamorelin safe for long-term use?

Because tesamorelin supports your own production rather than replacing the hormone, it is used as an ongoing plan with regular check-ins. Your clinician reviews how you feel and, when appropriate, lab work, and decides with you whether to continue, adjust or pause. Results tend to reverse if treatment stops.

Still have a question? Message our team

Ready to start with Tesamorelin?

$179/mo · $1,074 billed once for 6 months

Get started
  • Free shipping on every order
  • No membership fee
  • Same price at every dose
  • HSA and FSA accepted

More options in this area